Company Analysis
Sign in

Cellectis S.A. (CLLS)

Nasdaq: CLLS · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2014
Full chart Alerts Compare
Grade5.6
◀ Past 4.9● Present 5.4▶ Future 6.7
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 20, 2026Mar 14, 2025Apr 29, 2024Mar 14, 2023Mar 3, 2022Mar 4, 2021Mar 5, 2020Mar 12, 2019Mar 13, 2018Mar 23, 2017
Revenue72,949,00041,505,000755,00019,171,00030,347,000r51,057,000r15,190,00012,731,00025,188,00044,808,000
Cost of revenue00737,0001,772,0001,844,000r1,951,000r11,392,0002,739,0002,620,000·
Research and development93,517,00090,536,00087,646,00097,501,000117,840,000r77,048,000r92,042,00076,567,00079,227,00078,458,000
Selling, general and administrative19,790,00019,085,00016,812,00017,494,00022,882,000r22,513,000r43,017,00047,248,00044,750,00043,413,000
Total operating expenses·108,771,000106,495,000115,390,000142,077,000r101,875,000r146,542,000126,523,000126,366,000123,746,000
Operating income-33,076,000-59,554,000-97,302,000-89,666,000-103,481,000r-42,311,000r-123,552,000-105,091,000-92,650,000-67,302,000
Finance costs51,064,00021,614,00040,642,00017,815,0006,486,000r16,117,000r3,631,0003,813,00018,294,0007,101,000
Finance income16,124,00044,407,00021,479,0008,880,00013,218,000r4,846,000r11,971,00020,572,0007,262,0007,147,000
Net finance income (costs)-34,940,00022,793,000-19,163,000-8,935,0006,731,000r-11,270,000r8,340,00016,758,000-11,032,00046,000
Income before income taxes-68,016,000-36,761,000-116,464,000-98,601,000-96,749,000r-53,582,000r-115,212,000-88,333,000-103,683,000-67,255,000
Income tax expense-423,0000371,00087,000r000000
Income from continuing operations-67,593,000-36,761,000-116,835,000-98,688,000-96,749,000-53,581,000-115,212,000-88,333,000-103,683,000-67,255,000
Income from discontinued operations008,392,000-15,345,000-28,358,000r-43,902,000r-115,212,000-88,333,000r00
Net income-67,593,000-36,761,000-108,443,000-114,034,000-125,107,000-97,483,000-115,212,000-88,333,000-103,683,000-67,255,000
Net income to non-controlling interests00-7,384,000-7,894,000-10,910,000-16,409,000-13,121,000-9,640,000-4,315,000·
Net income to shareholders-67,593,000-36,761,000-101,059,000-106,139,000-114,197,000-81,074,000-102,091,000-78,693,000-99,368,000-67,255,000
Net income to ordinary shareholders··-101,059,000-106,139,000-114,197,000-81,074,000-102,091,000-78,693,000r-99,368,000r-67,255
Earnings per share, basic-0.67-0.41-1.77-2.33-2.55-1.91-2.41-1.93-2.78-1.91
Earnings per share, diluted-0.67-0.41-1.77-2.33-2.55-1.91-2.41-1.93-2.78-1.91
Weighted average shares, basic100,279,27690,566,34657,012,81545,547,35944,820,27942,503,44742,442,13640,774,19735,690,63635,274,890
Weighted average shares, diluted100,279,27690,566,34657,012,81545,547,35944,820,279·····
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldifrs-full:Revenue
Cost of revenue what it cost to make or buy what it soldifrs-full:CostOfSales
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherifrs-full:OperatingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Income from continuing operations profit from the businesses it keepsifrs-full:ProfitLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedifrs-full:ProfitLossFromDiscontinuedOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersifrs-full:ProfitLossAttributableToNoncontrollingInterests
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Net income to ordinary shareholders what is left for common shareholdersifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
Weighted average shares, diluted the average count with every share that could be issuedifrs-full:AdjustedWeightedAverageShares
SI Assistanton CLLS · research, not advice